| 12/2018 - Present |
Medical Director - Pediatrics |
UT Health San Antonio Physicians, Pediatrics, San Antonio, TX |
| 1/2018 - Present |
Associate Chair for Outreach |
UT Health San Antonio Lozano-Long School of Medicine, Pediatrics, San Antonio, TX |
| 9/2017 - Present |
Professor/Clinical non-Tenured |
UT Health San Antonio Lozano-Long School of Medicine, Pediatrics, San Antonio, TX |
| 11/2014 - Present |
Children's Oncology Group Responsible Investigator |
University of Texas Health Science Center, San Antonio, TX |
| 8/2012 - Present |
Children`s Cancer Research Institute Distinguished Chair in Pediatric Oncology |
UT Health San Antonio Lozano-Long School of Medicine, Pediatrics, San Antonio, TX |
Complement Dysfunction -
Specific scope related to complement dysregulation related diseases such as aHUS, PNH and the use of the complement (C5) inhibitor Eculizumab. |
Global Health -
Director of UTHeath-Southeast Asian Pediatric Hematology Oncology Initiative (UTSEAPHO) with activities/collaborations in southern Vietnam, Singapore, and Thailand. In 2017 UTSEAPHO became an active part of a larger international SEAPHO coalition including academic and research institutions such as University of California San Francisco, St Jude`s, University Health Systems, University of Medicine and Pharmacy of Ho Chi Minh City, Chulalongkorn University, as well as international foundations such as Kids With Cancer Foundation of Vietnam, Asian Children`s Cancer Care League, and World Child Cancer. I have also been a part of the planning committee and active participant in the National Cancer Institute (NCI) based Center for Global Health. |
OnControl Bone Marrow Biopsy Needle -
Principle investigator for powered bone marrow aspiration and biopsy device developed and by Vidacare. |
Oncofertility -
Co-Investigator; evaluating GnRH antagonist/agonist combination use in preserving chemotherapy induced ovarian dysfunction. Survivorship evaluations of females post cancer treatment and implications in fertility and gonadal function. |
Pediatric Hematology -
Expertise general benign hematologic disorders with emphasis on complement dysregulation, coagulopathies, marrow failure syndromes, and sickle cell disease. |
Pediatric Oncology -
Cancer center director and prior COG PI with research and clinical activity in the fields of cancer epidemiology, supportive care, therapeutic strategies, international health, and late effects. Currently, Responsible investigator for COG. |
Womens Hematologic Disorders -
Among women with heavy menstrual bleeding, it is estimated that 13% will have von Willebrands disease. This high prevalence warrants scientific exclusion of the diagnosis in any woman with abnormal uterine bleeding. Disease identification is important for guiding treatment options and potentially avoiding unnecessary surgery, in addition to patient education regarding the unique Ob/Gyn complications of the disease including heavy menstrual bleeding and postpartum hemorrhage. |
| Date |
Description |
Institution |
# Students |
| 9/2018 - Present |
Individual Instruction |
UT Health Long School of Medicine |
|
|
| 8/2018 - Present |
Individual Instruction |
UT Health San Antonio |
|
|
| 8/2016 - Present |
Individual Instruction |
University of Texas Health Science Center San Antonio School of Medicine |
|
|
| 5/2013 - Present |
Individual Instruction |
University of Texas Health Science Center San Antonio School of Medicine |
|
|
| 10/2012 - Present |
Individual Instruction |
UTHSCSA |
|
|
| 9/2011 - Present |
Pediatric Hematology/Oncology Fellow Lectures |
University of Texas Health Science Center San Antonio |
3 students |
| Part of the annual lecture series directed toward Pediatric Hematology and Oncology fellows reviewing core concepts. Specific topics personally provided include: chemotherapy pharmacology, complement disorders, acute leukemias, and lymphomas. |
| 2/2011 - Present |
Rotation Student Supervision |
University of Texas Health Science Center San Antonio |
|
|
| 2/2011 - Present |
Post-Doctoral Student Supervision |
University of Texas Health Science Center San Antonio |
|
|
| 2/2011 - Present |
Post Graduate Rotation Supervision |
University of Texas Health Science Center San Antonio |
|
|
Abstract |
| Huynh RA, Nguyen VS, Assanasen C. An Evaluation of Psychosocial Needs Among Healthcare Providers in Vietnam; 2019 Apr. (Pediatric Blood and Cancer; vol. 66, no. S2).
|
| Maida D, Brooks E, Forker C,
Assanasen C, Quigg T. Chronic Active Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis: Treatments and Outcome; 2019 Apr. (Pediatric Blood and Cancer; vol. 66, no. S2).
|
| Mullikin D, Ranch D, Lucari B, Khalfe Y, Assanasen C, Schafer E. Hispanic Children are at Increased Risk of Delayed Methotresxate Clearance and Severe Nephrotoxicity; 2019 Apr. (Pediatric Blood and Cancer; vol. 66, no. S2).
|
| Antequera A, Assanasen C. Atypical Hemolytic Uremic Syndrome (aHUS): An Emerging Pediatric Hematologic Disease; 2019 Apr. (Pediatric Blood and Cancer; vol. 66, no. S2).
|
| Blais D, Ranch D, Assanasen C. Delayed Methotrexate Clearance in Children, Can We Predict It?; 2015 Jun. (Pediatric Blood and Cancer; vol. 62, no. S2).
|
| Grimes, A, Robinson RD, Assanasen C, Knudton, J. Hormonal Suppression Experience for Ovarian Preservation During Chemotherapy; 2014 May. (Pediatric Blood and Cancer).
|
| Cruz A, Neff, P, Ranch D, Kubaney, H, Assanasen C. Atypical Hemolytic Uremic Syndrome in the Setting of Pre B ALL; 2014 May. (Pediatric Blood and Cancer).
|
| Guo N, Ranch D, Assanasen C. Acute Kidney Injury in Pediatric Acute Lymphoblastic Leukemia; 2014 May. (Pediatric Blood and Cancer).
|
| Lewis S, Thomas PJ, Aune GJ, Assanasen C. Intrathecal Cytarabine as substitution for Intrathecal Methotrexate in the setting of Neurotoxicity; 2014 May. (Pediatric Blood and Cancer).
|
| Assanasen C. Comparison of Rotary Powered Aspiration and Biopsy Device to the Traditional Manual Device in Children; 2014 Feb. (Pediatric Blood and Cancer; vol. 61, no. S1).
|
| Falcon-Cantrill M, Thomas PJ, Saldivar,V, Philbeck, T, Assanasen C. Comparison Of a Powered Bone Marrow Aspiration and Biopsy Device To The Traditional Manual Device In Children; 2013 Nov. (Blood; vol. 122, no. 21).
|
Editorial |
| Assanasen C. Associations between maternal factors during pregnancy and risk of acute lymphoblastic leukemia: Plausibility Rules Pediatric Blood and Cancer 2015 Mar;.
|
Journal Article |
| Meyer, M, Grimes M, Becker, E, Browning, J, Assanasen C, Libow, L, DeNapoli, T. Systemic Juvenile Xanthogranuloma:A Case Report and Brief Review Clin Exp Derm 2018 Feb;.
|
| Grimes A, Mirkeshti, N, Chatterjee B, Tomlinson G, Assanasen C. Paraneoplastic Galactorrhea in Childhood T-ALL: An Evaluation of Tumor- derived Prolactin J Pediatr Hematol Oncol 2017 Jan;39(1):e18-e20.
|
| Campbell JE, Assanasen C, Robinson RD, Knudtson JF. Fertility Preservation Counseling for Pediatric and Adolescent Cancer Patients J Adolesc Young Adult Oncol 2016 Mar;5(1):58-63.
|
| Ranch D, Crowther BR, Arar MY, Assanasen C. Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation Pediatric Transplantation 2014 Sep;18(6).
|
| Amin R, Bohnert A, Holmes L, Rajasekaran A, Assanasen C. Epidemiologic mapping of Florida childhood cancer clusters (Cover Page) Pediatr Blood Cancer 2010 Apr;54(4):511-518.
|
| Assanasen C, Mineo C, Seetharam D, Yuhanna IS, Marcel YL, Connelly MA, Williams DL, de la Llera-Moya M, Shaul PW, Silver DL. Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling J Clin Invest 2005 Apr;115(4):969-977.
|
| Assanasen C, Quinton RA, Buchanan GR. Acute myocardial infarction in sickle cell anemia J Pediatr Hematol Oncol 2003 Dec;25(12):978-981.
|
